Try our beta test site
274 studies found for:    cardiac CT OR CAT scan OR coronary artery scan | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Recruiting Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
Condition: Stage IIIA Non-Small Cell Lung Cancer
Interventions: Drug: Cisplatin;   Procedure: Computed Tomography;   Drug: Docetaxel;   Radiation: Fludeoxyglucose F-18;   Drug: Gemcitabine Hydrochloride;   Drug: Pemetrexed Disodium;   Procedure: Positron Emission Tomography
22 Recruiting 18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Conditions: Deep Fibromatosis/Desmoid Tumor;   Familial Adenomatous Polyposis
Interventions: Radiation: F-18 16 Alpha-Fluoroestradiol;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis
23 Recruiting Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma
Condition: Metastatic Renal Cell Cancer
Intervention: Procedure: perfusion computed tomography
24 Recruiting [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer
Conditions: Adult Liver Carcinoma;   Liver Cirrhosis
Interventions: Radiation: 18F-Fluoromisonidazole;   Procedure: Arterial Embolization;   Procedure: Computed Tomography;   Procedure: Positron Emission Tomography
25 Recruiting Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
Conditions: Arteriovenous Malformation;   Hemangioma;   Neoplasms Lymph Nodes;   Lymphedema
Intervention: Drug: 68Ga-NEB
26 Recruiting Prospective International Study of Coronary Subtraction Using 320 Detector Row CT (CorSub)
Condition: Coronary Artery Disease
Intervention:
27 Recruiting 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
Condition: Prostate Adenocarcinoma
Interventions: Drug: Gallium Ga 68-labeled GRPR Antagonist BAY86-7548;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
28 Recruiting Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients
Condition: Breast Cancer
Intervention: Drug: 68Ga-NOTA-BBN-RGD
29 Recruiting 68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Drug: 68Ga-NOTA-BBN-RGD
30 Recruiting 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas
Condition: Glioma
Interventions: Drug: 68Ga-NOTA-Aca-BBN;   Device: PET/CT
31 Recruiting 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
Conditions: Insulinoma;   Nesidioblastosis
Intervention: Drug: 68Ga-NOTA-exendin-4
32 Recruiting 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Conditions: Lung Carcinoma;   Solitary Pulmonary Nodule;   Cigarette Smoking Behavior
Interventions: Procedure: Computed Tomography;   Radiation: fluorodeoxyglucose F-18;   Drug: Fluorine F 18 L-glutamate Derivative BAY94-9392;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography;   Procedure: Positron Emission Tomography (PET)
33 Not yet recruiting Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery
Condition: Acoustic Neuroma
Intervention: Other: Testing of Pre-Positioning Frame
34 Recruiting Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors
Conditions: Neuroendocrine Tumors;   Von Hippel-Lindau Syndrome;   Hippel-Lindau Disease
Interventions: Drug: 68Gallium DOTATATE;   Procedure: Radio-guided surgery
35 Recruiting SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
Conditions: Lung Carcinoma;   Malignant Neoplasm
Interventions: Procedure: Computed Tomography;   Radiation: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc-99m Albumin Aggregated;   Drug: Technetium Tc-99m DTPA
36 Recruiting FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
Conditions: Estrogen Receptor Positive;   HER2/Neu Negative;   Progesterone Receptor Negative;   Progesterone Receptor Positive;   Stage IV Breast Cancer
Interventions: Procedure: Computed Tomography;   Drug: F-18 16 Alpha-Fluoroestradiol;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography
37 Recruiting Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients
Conditions: Oral Cavity Cancer;   Oropharyngeal Cancer;   Lymphedema;   Fibrosis
Interventions: Other: LEF measures;   Procedure: Technical measure
38 Recruiting High Image Matrix CT Reconstruction
Condition: Healthy Subjects
Intervention:
39 Recruiting CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy
Conditions: Malignant Lung Neoplasm;   Metastatic Malignant Neoplasm in the Lung;   Non-Small Cell Lung Carcinoma;   Stage IV Lung Cancer
Interventions: Radiation: Computed Tomography Perfusion Imaging;   Other: Laboratory Biomarker Analysis
40 Recruiting Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Condition: Healthy Subjects
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.